EQΦS measures what is not there — and the absence of evidence is itself a signal.
After 10 years of R&D and $400M raised, Theranos had published no article peer-reviewed. For a « revolutionary » medical innovation, it's a fatal signal.
| Verification | Result | Signification |
|---|---|---|
| PubMed "Theranos" | 0 result | None validation scientifique |
| PubMed "Elizabeth Holmes" | 0 result | The founder never published |
| Approbation FDA | None | Validation avoidance |
Transparency scientifique : nulle.
| Membre | Expertise | Medical competence |
|---|---|---|
| Henry Kissinger | Diplomatie | None |
| George Schultz | Diplomatie | None |
| James Mattis | Militaire | None |
| Sam Nunn | Senator | None |
Alignment competence ↔ mission : quasi nul.
None public demo of the Edison machine. NDA for everyone. Compartmentalized employees. Escorted visitors.
19 : 1
Notoriety ≈ 19× real transparency (normal alert threshold < 3:1).
| Cas | Result Theranos | Reality | Consequence |
|---|---|---|---|
| Patient 1 | HIV negative | HIV positif | No treatment |
| Patient 2 | Suspected cancer | Sain | Examens invasifs inutiles |
| Patient 3 | Coagulation OK | Trouble coagulation | Hemorrhagic risk |
BLOCK — the system is in ethical failure.
EQΦS output scores. The weighting and computation that produce them belong to the proprietary engine and are not published.
EQΦS aggregates the living axiss through a weighted geometric product — not an average. The exact mechanics, coefficients and constants of the Codex Universalis remain proprietary; the result, however, is public.
φ(S) = 0.085
The lowest viability score ever measured by EQΦS.
Three independent outputs, one verdict. The formula linking them belongs to the proprietary EQΦS engine.
Exigence : At least 1 article in JAMA, Lancet or NEJM proving the accuracy of capillary tests. If the technology works, this publication is trivial.
Impact : transparency 0.02 → 0.40
Theranos would NEVER have been able to — the technology didn't work. This single condition would have prevented $700M of investment.
Exigence : Lab access by an independent certified pathologist. Reproducibility verification on a standardized panel.
Impact : clarity 0.05 → 0.35
Theranos would have refused — and that refusal is an EQΦS block signal.
Exigence : At least 2 independent medical experts on the board (pathologist, hematologist). EQΦS requires real alignment between board expertise and mission.
Impact : integrity gouvernance 0.03 → 0.25
Exigence : FDA approval as a medical device (not CLIA exemption). The ethical safeguard imposes: if ethical risk confirmed → no-negotiable block.
Impact : security patients 0.04 → 0.30
Walgreens deployed across 40 pharmacies WITHOUT this validation. EQΦS would have blocked it.
4 conditions issued. None satisfiable.
40 pharmacies. Patients receive false results.
Carreyrou publishes. The technology doesn't exist.
4 fraud counts. Federal prison.
You just read the proof.
Computed on your data, your case, your framing. Not an opinion — a reproducible mathematical verdict.